"Muscarinic Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.
Descriptor ID |
D018721
|
MeSH Number(s) |
D27.505.519.625.120.140.500 D27.505.696.577.120.140.500
|
Concept/Terms |
Muscarinic Agonists- Muscarinic Agonists
- Agonists, Muscarinic
- Muscarinic Agonist
- Agonist, Muscarinic
- Cholinergic Muscarinic Agonists
- Agonists, Cholinergic Muscarinic
- Muscarinic Agonists, Cholinergic
- Cholinergic Agonist, Muscarinic
- Agonist, Muscarinic Cholinergic
- Muscarinic Cholinergic Agonist
- Cholinergic Agonists, Muscarinic
- Agonists, Muscarinic Cholinergic
- Muscarinic Cholinergic Agonists
|
Below are MeSH descriptors whose meaning is more general than "Muscarinic Agonists".
Below are MeSH descriptors whose meaning is more specific than "Muscarinic Agonists".
This graph shows the total number of publications written about "Muscarinic Agonists" by people in this website by year, and whether "Muscarinic Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscarinic Agonists" by people in Profiles.
-
Owen B, Bichler E, Benveniste M. Excitatory synaptic transmission in hippocampal area CA1 is enhanced then reduced as chronic epilepsy progresses. Neurobiol Dis. 2021 07; 154:105343.
-
Carpenter-Hyland E, Bichler EK, Smith M, Sloviter RS, Benveniste M. Epileptic pilocarpine-treated rats exhibit aberrant hippocampal EPSP-spike potentiation but retain long-term potentiation. Physiol Rep. 2017 Nov; 5(21).
-
Chen Z, Chen S, Chen L, Zhou J, Dai Q, Yang L, Li X, Zhou L. Long-term increasing co-localization of SCN8A and ankyrin-G in rat hippocampal cornu ammonis 1 after pilocarpine induced status epilepticus. Brain Res. 2009 May 13; 1270:112-20.
-
Rasmussen BA, Perry DC, O'Neil J, Manaye KF, Tizabi Y. Effects of nicotine on sensorimotor gating impairment induced by long-term treatment with neurotoxic NMDA antagonism. Neurotox Res. 2008 May-Jun; 13(3-4):151-61.
-
Lakshmanan J, Oyachi N, Ahanya SA, Liu G, Mazdak M, Ross MG. Corticotropin-releasing factor inhibition of sheep fetal colonic contractility: mechanisms to prevent meconium passage in utero. Am J Obstet Gynecol. 2007 Apr; 196(4):357.e1-7.
-
Ding J, Guzman JN, Tkatch T, Chen S, Goldberg JA, Ebert PJ, Levitt P, Wilson CJ, Hamm HE, Surmeier DJ. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci. 2006 Jun; 9(6):832-42.
-
Oyachi N, Lakshmanan J, Ahanya SN, Bassiri D, Atkinson JB, Ross MG. Development of ovine fetal ileal motility: role of muscarinic receptor subtypes. Am J Obstet Gynecol. 2003 Oct; 189(4):953-7.
-
Mej?as-Aponte CA, Jim?nez-Rivera CA, Segarra AC. Sex differences in models of temporal lobe epilepsy: role of testosterone. Brain Res. 2002 Jul 19; 944(1-2):210-8.
-
Aliev G, Seyidov D, Neal ML, Shi J, Vigan T, Hernandez A, Folco G, Soas AH, Zimina TV, Smith MA, Perry G, Lamanna JC, Friedland RP. The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro. J Submicrosc Cytol Pathol. 2001 Jan-Apr; 33(1-2):141-9.